| Symbol |
Name |
Standardized Value |
|
DRD2
|
dopamine receptor D2
|
1.65385
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
1.461
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
1.43552
|
|
FAM53B
|
family with sequence similarity 53, member B
|
1.41183
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
1.3821
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
1.34504
|
|
DRD3
|
dopamine receptor D3
|
1.3324
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
1.31974
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
1.3193
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
1.31231
|
|
MANEA
|
mannosidase, endo-alpha
|
1.2582
|
|
INTS8
|
integrator complex subunit 8
|
1.15453
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
1.13205
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
1.12994
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
1.12867
|
|
CPLX4
|
complexin 4
|
1.12024
|
|
OPRK1
|
opioid receptor, kappa 1
|
1.11898
|
|
CPLX3
|
complexin 3
|
1.08076
|
|
UBE3C
|
ubiquitin protein ligase E3C
|
1.06396
|
|
PDYN
|
prodynorphin
|
1.02102
|
|
HOMER2
|
homer scaffolding protein 2
|
1.00541
|
|
CALY
|
calcyon neuron-specific vesicular protein
|
0.999503
|
|
SNPH
|
syntaphilin
|
0.963728
|
|
MAOB
|
monoamine oxidase B
|
0.942858
|
|
OPRD1
|
opioid receptor, delta 1
|
0.904032
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
0.886799
|
|
CRH
|
corticotropin releasing hormone
|
0.876148
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
0.872872
|
|
SYT2
|
synaptotagmin II
|
0.86018
|
|
CDNF
|
cerebral dopamine neurotrophic factor
|
0.858543
|
|
VAMP1
|
vesicle-associated membrane protein 1 (synaptobrevin 1)
|
0.853631
|
|
CLOCK
|
clock circadian regulator
|
0.840525
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
0.834378
|
|
CPLX1
|
complexin 1
|
0.828229
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
0.821257
|
|
NPY5R
|
neuropeptide Y receptor Y5
|
0.808949
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
0.789672
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
0.776568
|
|
CPLX2
|
complexin 2
|
0.776568
|
|
IFI44L
|
interferon-induced protein 44-like
|
0.772479
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
0.755342
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
0.744766
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
0.736649
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
0.733406
|
|
SPATA21
|
spermatogenesis associated 21
|
0.730571
|
|
NCOR2
|
nuclear receptor corepressor 2
|
0.710378
|
|
POMC
|
proopiomelanocortin
|
0.703134
|
|
AKR7A3
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)
|
0.702732
|
|
TAC3
|
tachykinin 3
|
0.658422
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
0.651298
|
|
TPH2
|
tryptophan hydroxylase 2
|
0.650113
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
0.637889
|
|
PRL
|
prolactin
|
0.633563
|
|
MOGS
|
mannosyl-oligosaccharide glucosidase
|
0.629242
|
|
OPRM1
|
opioid receptor, mu 1
|
0.626888
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
0.623751
|
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
|
0.619442
|
|
HOMER1
|
homer scaffolding protein 1
|
0.610057
|
|
STXBP1
|
syntaxin binding protein 1
|
0.604201
|
|
SYT1
|
synaptotagmin I
|
0.591727
|
|
RAB3A
|
RAB3A, member RAS oncogene family
|
0.588612
|
|
TACR3
|
tachykinin receptor 3
|
0.587054
|
|
DAD1
|
defender against cell death 1
|
0.583941
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
0.581996
|
|
STX8
|
syntaxin 8
|
0.558285
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
0.556732
|
|
RGMB
|
repulsive guidance molecule family member b
|
0.55518
|
|
SIX4
|
SIX homeobox 4
|
0.537344
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
0.533861
|
|
MAOA
|
monoamine oxidase A
|
0.529994
|
|
COCH
|
cochlin
|
0.521888
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
0.51842
|
|
DRD1
|
dopamine receptor D1
|
0.510344
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
0.498849
|
|
PRDM16
|
PR domain containing 16
|
0.482844
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
0.476772
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
0.459373
|
|
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2
|
0.455978
|
|
NSF
|
N-ethylmaleimide-sensitive factor
|
0.437906
|
|
ARRB2
|
arrestin, beta 2
|
0.432646
|
|
ASPN
|
asporin
|
0.43227
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
0.430017
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
0.428891
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
0.425514
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
0.42214
|
|
ARRB1
|
arrestin, beta 1
|
0.36187
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
0.359657
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
0.356341
|
|
GDF5
|
growth differentiation factor 5
|
0.350084
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
0.331756
|
|
MARS
|
methionyl-tRNA synthetase
|
0.321181
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
0.301254
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
0.29118
|
|
COMT
|
catechol-O-methyltransferase
|
0.285444
|
|
BCHE
|
butyrylcholinesterase
|
0.280082
|
|
CORT
|
cortistatin
|
0.272953
|
|
CTSA
|
cathepsin A
|
0.257358
|
|
BEST1
|
bestrophin 1
|
0.252774
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
0.227297
|
|
STX1A
|
syntaxin 1A (brain)
|
0.211597
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
0.177851
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
0.165874
|
|
VCP
|
valosin containing protein
|
0.157929
|
